Quinidine

Half-Life (t½)
PO: 10.3h · IV: 10.3h
Formula
C20H24N2O2
Molecular Weight
324.42 g/mol
PubChem CID
441074

Pharmacological Mechanism

Class IA antiarrhythmic + Na+ + K+ channel blocker; also potent CYP2D6 + P-glycoprotein inhibitor → classic raises-digoxin example. Dextrorotatory stereoisomer of quinine. Largely supplanted by safer antiarrhythmics.

Half-Life & Elimination Curve (PO: 10.3h · IV: 10.3h)

100%50%25%12.5%0%0h0×t½10.3h1×t½20.7h2×t½31h3×t½41.4h4×t½51.7h5×t½0×t½ (0h): 100% remaining (~0.908 mg/L)1×t½ (10.3h): 50% remaining (~0.454 mg/L)2×t½ (20.7h): 25% remaining (~0.227 mg/L)3×t½ (31h): 12.5% remaining (~0.113 mg/L)4×t½ (41.4h): 6.3% remaining (~56.7 µg/L)5×t½ (51.7h): 3.1% remaining (~28.4 µg/L)
Plasma (PO)t½ Decay (10.3h)Effect Site (ke0)
  • 0×t½0h100% (0.908 mg/L)
  • 1×t½10.3h50% (0.454 mg/L)
  • 2×t½20.7h25% (0.227 mg/L)
  • 3×t½31h12.5% (0.113 mg/L)
  • 4×t½41.4h6.3% (56.7 µg/L)
  • 5×t½51.7h3.1% (28.4 µg/L)
Elimination t½10.3h (PO)
Rate Constant (ke)0.067 h⁻¹
Time to Peak (Tmax)2.17h
Est. Peak (Cmax)0.908 mg/L
Clearance (CL)13.4 L/h
97% Washout (5×t½)51.7h

Dosing Guidelines

Pharmacokinetic Parameters

Receptor Binding & Occupancy

Pathways It Modulates

Target Organ Systems

Interactions

Chemical Structure & Identifiers

References